Wesper, a platform which provides clinical grade FDA approved full cycle sleep therapy to home users just secured $7.5 million in a Series A funding primarily spearheaded by Ceros Capital Markets.
Wesper has disclosed its plans to fast-track growth drive expansion with the acquired funding. The company’s sleep therapy service involves providing sleep data to professionals to help them offer healthcare and develop sleep testing services.
The platform’s sensor and algorithms is used at home to source out medical diagnosis and continuous measurement at the three phases of pre treatment, treatment, and post treatment. In a nutshell Wesper users can access customized professional help from sleep specialists all in the comfort of their homes.
As originally reported in (https://www.finsmes.com/2022/11/wesper-raises-7-5m-in-series-a-funding.html)
